Clinical trial
Effect of a 15-day Donepezil Treatment on Biomarkers of AD in Healthy Volunteers
NCT01487395 is registered in ClinicalTrials.gov with University Hospital, Lille as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of a 15-day Donepezil Treatment on Biomarkers of AD in Healthy Volunteers
- Lead sponsor
- University Hospital, Lille
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- December 31, 2011
- Completion date
- December 31, 2013
- Enrollment
- 30 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
alzheimer disease, battery